New long-term data from Eli Lilly and Company (NYSE: LLY) show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease ...

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

Treatment failure occurs when an ulcerative colitis medication isn’t helping symptoms. Most important, know that it’s not your fault. Learn what to do next.

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

GRAND RAPIDS, Mich. — If the Crohn’s & Colitis Foundation has anything to say about it, a cure for Crohn’s, Ulcerative Colitis, and many other conditions could be right around the corner. And for ...

LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Arthritis is the most common nonintestinal complication for people with ulcerative colitis (UC). These tips can help stave it ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Today, AbbVie (NYSE: ABBV) has announced two positive updates for Canadians living with UC, including those in Ontario and ...

Take Steps is a walk event that brings communities together to support people with inflammatory bowel disease (IBD) and their families. The event is happening on Saturday, June 8th, at 10 a.m. at ...